Costs of breast cancer treatment incurred by women in Vietnam
Abstract Background There is a paucity of research on the cost of breast cancer (BC) treatment from the patient’s perspective in Vietnam. Methods Individual-level data about out-of-pocket (OOP) expenditures on use of services were collected from women treated for BC (n = 202) using an online survey and a face-to-face interview at two tertiary hospitals in 2019. Total expenditures on diagnosis and initial BC treatment were presented in terms of the mean, standard deviation, and range for each type of service use. A generalised linear model (GLM) was used to assess the relationship between total cost and socio-demographic characteristics. Results 19.3% of respondents had stage 0/I BC, 68.8% had stage II, 9.4% had stage III, none had stage IV. The most expensive OOP elements were targeted therapy with mean cost equal to 649.5 million VND ($28,025) and chemotherapy at 36.5 million VND ($1575). Mean total OOP cost related to diagnosis and initial BC treatment (excluding targeted therapy cost) was 61.8 million VND ($2667). The mean OOP costs among patients with stage II and III BC were, respectively, 66 and 148% higher than stage 0/I. Conclusions BC patients in Vietnam incur significant OOP costs. The cost of BC treatment was driven by the use of therapies and presentation stage at diagnosis. It is likely that OOP costs of BC patients would be reduced by earlier detection through raised awareness and screening programmes and by providing a higher insurance reimbursement rate for targeted therapy..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
BMC Public Health - 22(2022), 1, Seite 10 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tran Thu Ngan [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Breast cancer |
|---|
| doi: |
10.1186/s12889-021-12448-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ076027228 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ076027228 | ||
| 003 | DE-627 | ||
| 005 | 20230502142257.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230228s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12889-021-12448-3 |2 doi | |
| 035 | |a (DE-627)DOAJ076027228 | ||
| 035 | |a (DE-599)DOAJdde8977813ba43808d87cb8145c9d779 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RA1-1270 | |
| 100 | 0 | |a Tran Thu Ngan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Costs of breast cancer treatment incurred by women in Vietnam |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Background There is a paucity of research on the cost of breast cancer (BC) treatment from the patient’s perspective in Vietnam. Methods Individual-level data about out-of-pocket (OOP) expenditures on use of services were collected from women treated for BC (n = 202) using an online survey and a face-to-face interview at two tertiary hospitals in 2019. Total expenditures on diagnosis and initial BC treatment were presented in terms of the mean, standard deviation, and range for each type of service use. A generalised linear model (GLM) was used to assess the relationship between total cost and socio-demographic characteristics. Results 19.3% of respondents had stage 0/I BC, 68.8% had stage II, 9.4% had stage III, none had stage IV. The most expensive OOP elements were targeted therapy with mean cost equal to 649.5 million VND ($28,025) and chemotherapy at 36.5 million VND ($1575). Mean total OOP cost related to diagnosis and initial BC treatment (excluding targeted therapy cost) was 61.8 million VND ($2667). The mean OOP costs among patients with stage II and III BC were, respectively, 66 and 148% higher than stage 0/I. Conclusions BC patients in Vietnam incur significant OOP costs. The cost of BC treatment was driven by the use of therapies and presentation stage at diagnosis. It is likely that OOP costs of BC patients would be reduced by earlier detection through raised awareness and screening programmes and by providing a higher insurance reimbursement rate for targeted therapy. | ||
| 650 | 4 | |a Breast cancer | |
| 650 | 4 | |a Direct cost | |
| 650 | 4 | |a Out-of-pocket expenditure | |
| 650 | 4 | |a Vietnam | |
| 653 | 0 | |a Public aspects of medicine | |
| 700 | 0 | |a Nguyen Bao Ngoc |e verfasserin |4 aut | |
| 700 | 0 | |a Hoang Van Minh |e verfasserin |4 aut | |
| 700 | 0 | |a Michael Donnelly |e verfasserin |4 aut | |
| 700 | 0 | |a Ciaran O’Neill |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t BMC Public Health |d BMC, 2003 |g 22(2022), 1, Seite 10 |w (DE-627)DOAJ000057509 |x 14712458 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2022 |g number:1 |g pages:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12889-021-12448-3 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/dde8977813ba43808d87cb8145c9d779 |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12889-021-12448-3 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1471-2458 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2022 |e 1 |h 10 | ||